Michael Flanagan

Michael Flanagan has an extensive work experience in the finance and accounting field. Michael began their career as an Assistant Controller at Genuity in 1995 and held this position until 2000. Michael then joined EMD Serono as the Director of Accounting from 2002 to 2004, before becoming the Reproductive Health Controller from 2005 to 2006. Flanagan worked at Momenta Pharmaceuticals as a Controller from 2006 to 2012. Following this, they served as the Vice President of Finance at OvaScience from 2012 to 2013. Flanagan then worked at Sarepta Therapeutics as the Corporate Controller from 2013 to 2017. Currently, they are the Vice President, Corporate Controller at SAGE Therapeutics, commencing from April 2017.

Michael Flanagan attended Northeastern University, where they did not specify a start or end year, and did not mention any degree or field of study.